Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
S Urban, C Neumann-Haefelin, P Lampertico - Gut, 2021 - gut.bmj.com
Approximately 5% of individuals infected with hepatitis B virus (HBV) are coinfected with
hepatitis D virus (HDV). Chronic HBV/HDV coinfection is associated with an unfavourable …
hepatitis D virus (HDV). Chronic HBV/HDV coinfection is associated with an unfavourable …
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …
A phase 3, randomized trial of bulevirtide in chronic hepatitis D
Background Coinfection with hepatitis D virus (HDV) accelerates the progression of liver
disease associated with chronic hepatitis B. Bulevirtide inhibits the entry of HDV into …
disease associated with chronic hepatitis B. Bulevirtide inhibits the entry of HDV into …
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
P Lampertico, K Agarwal, T Berg, M Buti… - Journal of …, 2017 - Elsevier
Hepatitis B virus (HBV) infection remains a global public health problem with changing
epidemiology due to several factors including vaccination policies and migration. This …
epidemiology due to several factors including vaccination policies and migration. This …
Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
HY Chen, DT Shen, DZ Ji, PC Han, WM Zhang, JF Ma… - Gut, 2019 - gut.bmj.com
Objective Hepatitis D virus (HDV) is a defective virus that completes its life cycle only with
hepatitis B virus (HBV). The HBV with HDV super-infection has been considered as one of …
hepatitis B virus (HBV). The HBV with HDV super-infection has been considered as one of …
The changing context of hepatitis D
The global epidemiology of hepatitis D is changing with the widespread implementation of
vaccination against hepatitis B. In high-income countries that achieved optimal control of …
vaccination against hepatitis B. In high-income countries that achieved optimal control of …
Bulevirtide with or without pegIFNα for patients with compensated chronic hepatitis delta: From clinical trials to real-world studies
P Lampertico, D Roulot, H Wedemeyer - Journal of hepatology, 2022 - Elsevier
Chronic hepatitis D (CHD) is the most severe form of viral hepatitis, characterised by the
greatest increase in risk of cirrhosis, hepatic decompensation and hepatocellular carcinoma …
greatest increase in risk of cirrhosis, hepatic decompensation and hepatocellular carcinoma …
EASL Clinical Practice Guidelines on hepatitis delta virus
Hepatitis D virus (HDV) is a defective virus that requires the hepatitis B virus to complete its
life cycle and cause liver damage in humans. HDV is responsible for rare acute and chronic …
life cycle and cause liver damage in humans. HDV is responsible for rare acute and chronic …
[PDF][PDF] Guidance for design and endpoints of clinical trials in chronic hepatitis B—report from the 2019 EASL‐AASLD HBV Treatment Endpoints Conference
Representatives from academia, industry, regulatory agencies, and patient groups
convened in March 2019 with the primary goal of developing agreement on chronic hepatitis …
convened in March 2019 with the primary goal of developing agreement on chronic hepatitis …
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
P Bogomolov, A Alexandrov, N Voronkova… - Journal of …, 2016 - Elsevier
Background & Aims The therapeutic option for patients with chronic hepatitis delta virus
infection (CHD) is limited to interferon alpha with rare curative outcome. Myrcludex B is a first …
infection (CHD) is limited to interferon alpha with rare curative outcome. Myrcludex B is a first …